Skip Intro


Neochord, Inc. is developing a minimally invasive device that replaces a procedure currently done with open heart surgery to reduce mitral regurgitation. Approximately 200 patients have been treated with this device in Europe (CE Mark achieved) and the company will initiate the US IDE study later this year.